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Introduction 1
Transcranial focused ultrasound (FUS) delivers targeted ultrasound energy to specific brain 2 regions without damaging intervening tissue or requiring skull removal (Martin and Werner  3 2013; Lipsman et al. 2014 ). Importantly, transcranial FUS avoids the risks associated with 4 invasive procedures (e.g., bleeding, infection) while maintaining high spatial resolution and the 5 ability to reach subcortical targets, which limit other neurosurgical and neurostimulatory 6 methods. 7
A potentially transformative application of transcranial FUS is neuromodulation, which is 8 thought to be a noninvasive method to explore brain function and circuitry (Tyler, Lani, and 9 Hwang 2018). Neuromodulation uses short bursts of low intensity ultrasound to excite or 10 inhibit neural activity and can be targeted to subcortical structures at the scale of a few 11 millimeters, which cannot be achieved by other noninvasive neuromodulation modalities such 12 as transcranial magnetic or electrical stimulation (Monti et al. 2016 ; Naor, Krupa, and Shoham 13 2016; Fomenko et al. 2018 ). This could enable functional mapping of small nuclei for treatment 14 targeting and for advancing neuroscience, and offer a possible treatment for neurological 15 conditions (Kubanek 2018 animal publications showed no abnormal histologic findings (Blackmore et al. 2019) . Included in 21 the fourteen studies were two large animal studies, one in pigs (Dallapiazza et al. 2017 ) and one 22 in macaques (Verhagen et al. 2019) , which found no tissue damage resulting from FUS 23 neuromodulation. However, one study in sheep raised concerns of microhemorrhage after 24 exposure to prolonged, repetitive FUS neuromodulation (W. Lee, Lee, et al. 2016 ). Thus, the 25 first purpose of this work was to ascertain whether neuromodulation poses a risk of tissue 26 microhemorrhage in sheep as suggested by Lee et al., with the addition of controls not treated 27 with FUS, and in rhesus macaques . 28 In addition, FUS neuromodulation is aided by confirmation of FUS targeting in the brain. MR 29 acoustic radiation force imaging (MR-ARFI) uses a series of very short FUS bursts at higher 30 intensity to visualize the ultrasound focal spot in situ. The ultrasound pulses slightly displace 31 tissue which, in synchrony with MRI, can be detected as a shift in image phase (McDannold and  32 Maier 2008). This phase shift is proportional to the ultrasound intensity applied, and therefore 33
can provide a non-invasive metric of the intensity delivered at the focal spot. MR-ARFI can also 34 be used to assess and compensate for distortion of the ultrasound through the skull. Almost no assessments of MR-ARFI safety have been reported. Two reports of in vivo MR-ARFI 1 in the body, one in rabbits (Huang et al. 2009 ) and one in pigs (Holbrook et al. 2011 ), have been 2 published but did not discuss safety. One study involving transcranial MR-ARFI in two macaques 3 has been published, but did not include histology (Chaplin et al. 2019 ). To our knowledge, the 4 only report of MR-ARFI safety is from a study that investigated histology after transcranial MR-5 ARFI in one rodent, in which no tissue damage was observed (Larrat et al. 2009 ). The second 6 purpose of this work was to assess tissue safety in a controlled study of transcranial MR-ARFI in 7
sheep. 8
We evaluate histology in brain tissue following FUS neuromodulation in the visual cortex of 9 rhesus macaques, and following neuromodulation and MR-ARFI in subcortical brain regions in 10
sheep. The sheep histology includes a treatment control group in which no FUS was applied, 11
and internal controls from hemispheres not treated with FUS. Our neuromodulation protocols 12
included a component similar to those used in human studies, and to those evaluated by Lee 13 and colleagues. We also investigated a broader range of intensity values and repeated number 14 of FUS bursts, exceeding those values typically used in human protocols as well as those used in 15
the study by Lee (NHP-1 and NHP-2) were clinically healthy on physical examination and were seronegative for 24 the following pathogens: Mycobacterium tuberculosis, simian immunodeficiency virus, and 25
simian T-lymphotrophic virus type 1 and 2. One animal was seropositive for simian retrovirus. 26 Animals were housed in indoor caging and maintained on a 12:12 hr light:dark cycle in an 27 AAALAC-accredited facility. Animals were fed a commercial primate diet (Teklad Global 20%  28 Protein Primate Diet 2050, Envigo, Madison, WI) supplemented with fresh produce, and had 29 unrestricted access to water. Figure 1 (a) summarizes study characteristics. 30
Anesthesia and preparation 31
Both animals were sedated with ketamine (4 mg/kg, intramuscularly) and dexmedetomidine 32 (0.02 mg/kg, intramuscularly) and anesthetized with 2-3% isoflurane throughout the FUS 33 procedure. The hair was shaved from the back of the head prior to transducer placement. 34
Focused ultrasound 1
A single-element, 270 kHz focused ultrasound transducer fitted with an agar-filled cone was 2 positioned at the back of the head and coupled with degassed ultrasound gel as illustrated in 3 Fig. 1(b FUS was targeted to four regions in the visual cortex as shown in Fig. 1(c) . A coupling cone was 5 used such that the ultrasound focus was positioned at the surface of the brain (5 cm length 6 from transducer). The focal pressure half-width was approximately 17 mm in the axial direction 7 and 6 mm in the lateral direction. The lower two focal spot locations were placed 2 mm above 8
the center of the inion and spaced bilaterally by 15 mm (NHP-1) and 20 mm (NHP-2). The upper 9
two focal spot locations were located directly above at 10 mm (NHP-1) or 15 mm (NHP-2). 10 FUS was applied in 300 ms pulsed (50% duty cycle) bursts occurring every 1 s for a total of 500 11 stimuli, as illustrated in Fig. 1(d) . One 8.3 min FUS trial (comprising 500 FUS bursts) was applied 12
to each of the four neuromodulation locations. Free-field stimulus pressure levels 13 corresponded to 0.5, 1, 2, and 4 MPa as measured in a water tank by fiberoptic hydrophone 14 (Precision Acoustics, Dorset, UK), in order to sample a range of values. In situ intensity was 15 estimated after assuming approximately 40% pressure loss through the macaque skull, based 16 on reports from a previous study (Deffieux et al. 2013 hemisphere, as illustrated in Fig. 1(c) . 20
Fixation and histopathology 21
Thirty minutes following FUS, the animals were anesthetized to a surgical plane with 5% 22
isoflurane and initially perfused with 0.25-0.5 liters of saline. Next, the macaques were 23 perfused with 4 liters of 3.5% to 4% paraformaldehyde in 0.1 M phosphate buffer at high 24 pressure for 2-3 minutes (2 liters) and at low pressure (2 liters) for one hour. Lastly, they were 25 perfused with 1-1.25 liters each of 10%, 20%, and 30% sucrose solutions at high pressure for 26 cryoprotection. The skull was removed using an autopsy saw (Shandon, ThermoFisher Scientific, 27
No. 10000) and the brain was extracted. The primary visual cortex was segmented from the 28 remaining cortex by making a coronal cut 2 mm posterior to the lunate sulcus. Brains were then 29 immersion-fixed in 10% neutral buffered formalin for 7-10 days. Formalin-fixed tissues were 30 then processed routinely, embedded in paraffin, sectioned at 7 m, and stained with 31 hematoxylin and eosin (H&E). Three coronal tissue sections were obtained from each 32
hemisphere of the visual cortex, resulting in six total sections per macaque ( Fig. 1(c Sheep were divided into FUS (n=11) and control (n=2) study groups. Animals that received FUS 5
were subdivided into four groups as follows: acute (n=2; euthanized zero days after FUS study), 6 delayed (n=3; euthanized four to seven days after FUS study), repeated (n=3; underwent FUS 7 again three to six days after the first FUS session, and euthanized four days after the last FUS 8 study), and high dose (n=3; received multiple FUS sessions with prolonged application of FUS on 9
the last day of study, and euthanized four days later). Both sheep in the control group 10 underwent multiple days of MRI study. The two sheep in the acute FUS group and one sheep in 11 the delayed FUS group also underwent MRI study on one or more days prior to the FUS session. 12 Study characteristics are summarized in Fig. 2 (a). 13
Anesthesia and preparation 14
Sheep were fasted for 24 hours prior to the study and then sedated with tiletamine and 15 zolazepam (Telazol, Lederele Parenterals, Carolina, Puerto Rico) at 4 mg/kg, intramuscularly. 16 Anesthesia was induced with a combination of 3% isoflurane in oxygen delivered by facemask 17 and telazol in a continuous rate of infusion. All animals were orotracheally intubated and 18
anesthesia was maintained with 1% to 3% isoflurane in oxygen with MRI conditional mechanical 19 ventilation (Omni-Vent Series D, Allied Healthcare Products, St. Louis, MO) to maintain end-20 tidal carbon dioxide between 35 mm Hg and 45 mm Hg. Stomach tubes were placed after 21 intubation to resolve gaseous distension and prevent regurgitation. Venous and arterial 22
catheters were placed percutaneously for drug and fluid administration and blood pressure 23
monitoring. Lactated Ringer's solution (Abbott Laboratories, Abbott Park, IL) was administered 24
intravenously at approximately 10 mL/kg/hr throughout anesthesia. The top of the head was 25 shaved and treated with a depilatory cream for hair removal. 26
Physiological monitoring 27
Serial samples of hematocrit and arterial blood gases were taken from the auricular arterial 28 catheter. Blood gas samples were analyzed immediately on a calibrated blood gas analyzer (i- 29 STAT, Abbott Point of Care, East Windsor, NJ). Pulse oximetry measurements and capnography 30 were performed continuously during anesthesia (Expression MR400, Philips Healthcare, Vantaa, 31
Finland). 32 MR-guided focused ultrasound 33 MR-guided focused ultrasound studies were conducted using a 1024 element, 550 kHz focused 34 ultrasound transducer fitted with a membrane containing chilled, degassed water (ExAblate 35 2100, Insightec Ltd., Haifa, Israel). The transducer was positioned above the head with 36 degassed ultrasound gel for acoustic coupling (Fig. 2(b) ). 37
Acoustic coupling and focal spot location were verified by MR-ARFI in the eleven sheep that 1 underwent transcranial FUS. Figure 2 (d) illustrates the MR-ARFI protocol in which FUS was on 2 for 16 ms bursts within a 500 ms window (corresponding to the MR repetition time) over a 3 period of 1.2 min. Each application of MR-ARFI comprised 128 FUS bursts. Figure 2 (e-g) 4 illustrates neuromodulation protocols, in which FUS was on for 200-300 ms bursts every 1 s 5 with continuous wave (Fig. 2(f) ) or pulsed (50% duty cycle) ultrasound ( Fig. 2(e,g) ). Each 6 neuromodulation application comprised 120 ( Fig. 2(e) ) or 600 FUS bursts ( Fig. 2(f,g) ) over a 7 period of 6 ( Fig. 2 (e)) or 20 minutes ( Fig. 2(f,g) ). The protocols applied for each sheep are 8 reported in Fig. 2(a) . FUS pulse timing was controlled by Eprime scripts (Psychology Software 9
Tools, Pittsburgh, PA). 10
Multiple MR-ARFI and neuromodulation trials were administered consecutively to investigate 11 the safety of repeated FUS sonications. The within-session timing of FUS application is 12 illustrated in Fig. 3 for each sheep. Applied acoustic powers ranged from 127.5-195.5 W for MR-13
ARFI and 2-34 W for neuromodulation, and are summarized in Fig. 4 (a) and Fig. 4(d to evaluate potential effects at higher levels. 18
MR-ARFI and neuromodulation were targeted to 1-6 and 1-4 subcortical locations, respectively. 19 The neuromodulation study measured visual evoked potentials using scalp electrodes in 20
response (sheep 9). The total number of FUS bursts applied to each targeted location are illustrated for 28
MR-ARFI in Fig. 4 (g) and for neuromodulation in Fig. 4 Cardiac arrest was confirmed by auscultation. Skulls were removed via an autopsy saw 12
(Shandon, ThermoFisher Scientific, No. 10000) and brains were extracted and immersion-fixed 13
in 10% neutral buffered formalin for at least 10 days. Following fixation, the entirety of the 14 brain was sectioned at approximately 3 mm intervals in the coronal plane. Brain regions were 15
selected for histologic evaluation based on gross tissue comparison to MRI locations of FUS 16
targets. Coronal tissue sections included the FUS target and all tissue dorsal to this region (to 17 evaluate for potential cortical effects from skull heating and any effects within the FUS beam 18 path). Additional tissue sections at distances of +/-3 mm from FUS targets were evaluated 19 histologically ( Fig. 2(c) ). Tissue sections were also evaluated from contralateral, untreated 20
hemispheres of acute and delayed FUS groups (internal controls). In control sheep, tissue 21 sections were taken from the left and right hemispheres in locations anatomically similar to the 22 FUS group. Formalin-fixed tissues were processed routinely, embedded in paraffin, sectioned at 23 5 m, and stained with H&E. Slides were blindly reviewed by a board-certified veterinary 24 pathologist (KMC). Particular attention was paid to the presence or absence of hemorrhage, as 25 well as pre-mortem tissue responses to damage (i.e., necrosis, red blood cell engulfment 26 (erythrophagocytosis), and intracellular red blood cell breakdown (hemosiderin-laden 27 macrophages)). Additionally, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick 28 end labeling (TUNEL) staining (ApopTag kit; Millipore, Temecula, CA) was performed according 29
to manufacturer's instruction on tissue sections corresponding to locations receiving the 30 highest number of MR-ARFI repetitions from sheep in the high dose group. 31
Hydrophone measurements 32
Ex vivo skull caps from each sheep were degassed and placed in front of the focused ultrasound 33 transducer array in a tank with degassed water. A fiberoptic hydrophone was positioned at the 34 ultrasound focus to measure peak negative pressure transmitted through each skull cap to 35 obtain an in situ intensity estimate for each acoustic power level applied in vivo (Precision 36
Acoustics, Dorset, UK). 37 Results 1 Rhesus macaque study 2 Histopathology 3
Post-mortem examination of the extracted brain tissue did not reveal any macroscopic damage. 4 A total of 12 H&E slides of brain tissue were evaluated: six slides, sampling left and right 5
hemispheres, from two macaques. Histologic evaluation of tissue containing the focused 6 ultrasound beam path from the four targeted locations did not show any evidence of damage in 7 either macaque (Fig. S1 ). Specifically evaluated parameters included necrosis, apoptosis, 8 edema, hemorrhage, inflammation, and neuropil rarefaction. Red blood cell extravasation could 9
not be evaluated as these animals were perfused (i.e., exsanguinated) prior to histologic 10 examination. 11
Sheep study 12 Estimates of in situ ultrasound intensity were obtained based on hydrophone measurements of 13 pressure transmitted through each ex vivo skull cap. The acoustic power levels applied during 14
the study corresponded to in situ peak pressure estimates of 1.7-3.6 MPa for MR-ARFI ( Fig.  15 4(b)) and 0.25-0.9 MPa for neuromodulation ( Fig. 4(e) ), and in situ I estimates ranging from 16 5.6-26.5 W/cm for MR-ARFI ( Fig. 4(c) ) and 0.6-13.8 W/cm for neuromodulation ( Fig. 4(f) ). 17
The number of FUS bursts applied to each location are stratified by the estimated in situ peak 18 pressure and intensity of the sonication as shown in Fig. 5 for MR-ARFI and neuromodulation. 19 Observations at multiple locations of the same number of bursts and estimated pressure or 20
intensity are indicated by the color scale. High peak pressure values for MR-ARFI sonications 21
were applied for short durations of 16 ms within the pulse repetition period, resulting in 22 temporal average intensities that were similar to or slightly higher than the neuromodulation 23 I estimates, despite much lower neuromodulation peak pressures. In all sheep, transcranial 24 FUS was confirmed by visualization of the focal spot by MR-ARFI with targeting to at least one 25 subcortical location ( Fig 6) . 26
Histopathology 27
Overall, a total of 183 H&E slides of brain tissue from 13 sheep were evaluated for histologic 28 damage. Of these, 128/183 received direct FUS exposure (sampled at the focal spot location 29 and/or 3 mm rostral/caudal), 19/183 were internal controls (i.e., contralateral hemisphere to 30 that which received FUS), and 36/183 were experimental controls (i.e., no FUS to either 31 hemisphere). Overall, no FUS-related pre-mortem histologic findings were noted in any of the 32 examined slides. Figure 7 summarizes the frequency of post-mortem histologic findings across 33 study groups. The presence of each finding is reported for each hemisphere, where green boxes 34 outline hemispheres that received FUS. The color scale represents the percentage of H&E slides 35 that were positive for each histologic feature. 36
Histologic findings were limited to post-mortem red blood cell extravasation (meningeal or 1 parenchymal) following brain extraction. Red blood cell extravasation was never observed at 2 the precise sites of FUS targets. When present, parenchymal post-mortem red blood cell 3 extravasations were randomly distributed within tissues distant to the FUS target. The number 4 of incidences (foci) of scattered red blood cell extravasation in the parenchyma was quantified 5
for each tissue section (Fig. 8 ). Our results suggest the rate of parenchymal red blood cell 6 extravasation did not increase with FUS, but equivalence tests between FUS and control 7 sections were not statistically significant. We performed a cluster-adjusted logistic regression 8 and found the risk of red blood cell extravasation in the meninges is equivalent within +/-10% 9 with p<0.05 between FUS treated and untreated tissue sections. 10
Acute FUS group 11
Histologically, sheep euthanized less than 24 hours (n=2) following MRI and FUS exhibited red 12 blood cell extravasation within the meninges (2/2) as well as rare perivascular red blood cells 13 within neural parenchyma (2/2), regardless of hemispheric location (left vs right) and FUS 14 application ( Fig. 9 (a,b,h,i)). No concurrent pre-mortem histologic findings (i.e., necrosis, red 15 blood cell engulfment (erythrophagocytosis), and intracellular red blood cell breakdown 16
(hemosiderin-laden macrophages)) were noted in areas of red blood cell extravasation. 17
However, acute hemorrhage can be histologically indistinguishable from post-mortem red 18 blood cell extravasation (Finnie 2016 ). Thus, a delayed euthanasia timepoint was established to 19 confirm that red blood cell extravasation was indeed a post-mortem tissue extraction artifact 20 rather than true pre-mortem hemorrhage. 21
Delayed FUS group 22
In order to confirm that extravascular red blood cells seen in the acute FUS group reflected 23 artifact following post-mortem tissue extraction, a delayed euthanasia timepoint was 24 established (4-to 7-days post-FUS). In general, approximately 2-to 4-days following meningeal 25 (or subarachnoid) hemorrhage, a normal response to hemorrhage should include 26 erythrophagocytosis, while hemosiderin-laden macrophages are typically seen around 6-to 7-27 days post-hemorrhage (Finnie 2016; Rao et al. 2016 ). In our study, sheep euthanized 96-168 28 hours following MRI and FUS exhibited extravascular red blood cells within the meninges (3/3) 29 and rare extravascular red blood cells within neural parenchyma (2/3), regardless of 30 hemispheric location (left vs right) and FUS application ( Fig. 9(c,d,j,k) ). Furthermore, at 96-168 31 hours following FUS, there was still no evidence of concurrent histologic abnormalities (such as 32 those listed above) in regions of red blood cell extravasation. 33
Repeated FUS group 34
Tissue from sheep treated with FUS over multiple days exhibited extravascular red blood cells 35 within the meninges (3/3) similar to the other groups. Occasional perivascular red blood cells 36 were observed bilaterally within the neural parenchyma for one sheep (sheep 10; Fig. 9(e,l) ). 37
No other concurrent pre-mortem histologic findings (i.e., necrosis, macrophage infiltration, red 38 blood cell engulfment (erythrophagocytosis), and intracellular red blood cell breakdown 39
(hemosiderin-laden macrophages)) were observed. 40 1 Sheep in the high dose group received prolonged consecutive MR-ARFI sonication to a single 2 location on the last day of study, with the total number of MR-ARFI applications at the high 3 dose location (25, 44 , and 70 repetitions for sheep 11, 12, and 13, respectively) greatly 4
exceeding the highest number of repetitions applied within the other FUS groups (8 repetitions  5 for sheep 10). Neuromodulation sonications were similar to those applied in the other FUS 6
groups. As with sheep in other groups, extravascular red blood cells were noted in the 7 meninges (3/3) and rarely in parenchyma (3/3) ( Fig. 9(f,m) ). No other histologic findings 8
accompanied extravascular red blood cells. Additionally, no histologic findings were observed at 9
the high dose location or other locations targeted with FUS in any sheep. TUNEL results confirm 10 no evidence of apoptosis at the high dose location for all three sheep (Fig. S2) . 11
Control group 12
Control animals that only underwent the MRI procedure (i.e., no FUS) also exhibited red blood 13 cell extravasation within the meninges (2/2) and rarely within neural parenchyma (2/2) ( Fig.  14  9(g,n) ). As with sheep that underwent FUS, no evidence of concurrent pre-mortem histologic 15 findings (i.e., necrosis, macrophage infiltration, red blood cell engulfment 16 (erythrophagocytosis), and intracellular red blood cell breakdown (hemosiderin-laden 17 macrophages)) was observed in areas of red blood cell extravasation. 18
Discussion 19
The results of this study suggest that the transcranial MR-ARFI and neuromodulation FUS 20 protocols evaluated did not result in histologic tissue damage. No histologic abnormalities were 21 observed at the site of FUS targets in either rhesus macaques or sheep, although post-mortem 22 parenchymal red blood cell extravasation was observed in other brain regions of sheep tissue 23 sections (i.e., away from the focal spot). 24
Histologic findings were similar in both FUS treated and untreated hemispheres, as well as in 25 control groups. Tissue sections from all sheep exhibited red blood cell extravasation in the 26 meninges regardless of FUS application, treated hemisphere, or survival time (Fig 7) . Through 27 the process of post-mortem skull removal, meningeal blood vessels (e.g., dural) are frequently 28 ruptured resulting in the observed meningeal red blood cell extravasation. Furthermore, 29 vibrations during extraction are strong enough to result in rare extravasations of red blood cells 30 from parenchymal vessels. Multiple sections from both FUS (treated and untreated 31 hemispheres) and control groups exhibited perivascular red blood cell extravasation in cortical 32 tissue regions separate from those identified as FUS targets (Fig 8) . No macrophage infiltration, 33 erythrophagocytosis, hemosiderin-laden macrophages, tissue necrosis, or other indicators of 34 tissue reactivity to damage were observed ( Fig. 7) , confirming post-mortem artifact. 35
Selecting appropriate euthanasia time points is crucial to interpreting histologic findings. At 36 time points less than 24 hours, true small volume hemorrhage can be indistinguishable from 37 tissue damage incurred during post-mortem brain extraction (Maxie 2007) . Following 72 hours, 38 true pre-mortem hemorrhage should exhibit concurrent macrophage infiltration, 1 erythrophagocytosis, and/or hemosiderin-laden macrophages (Rao et al. 2016 ). The absence of 2 this expected tissue reactivity within our sheep cohort confirm that meningeal and 3 extravascular red blood cells seen across both hemispheres and experimental groups were 4 artifact due to post-mortem tissue extraction. 5
We evaluated in situ intensities similar to and slightly higher than previously reported I 6
values of up to 4.4 W/cm in humans, 9.5 W/cm in macaques, and 6.7 W/cm in sheep (W. 7 Lee reported microhemorrhage on H&E-stained tissue following 500 or more bursts of 9 neuromodulation (300 ms long burst duration repeated in 1 second intervals at 50% duty cycle) 10 at 3.3-5.7 W/cm , but not at 6.7 W/cm I . Of fifteen publications assessing histology after 11 neuromodulation, this was the only one to report abnormal findings, as summarized in a recent 12 review of the ultrasound neuromodulation literature (Blackmore et al. 2019 ). However, 13
because these foci of microhemorrhage were identified 4-64 days following treatment, with an 14 absence of concurrent parenchymal reaction, we speculate that this finding may in fact be a 15 post-mortem artifact. 16
In our study, repeated FUS neuromodulation and MR-ARFI sonications to the same focal spot 17 location, either within one session or on multiple days, at various intensity levels, were not 18 accompanied by histologic damage. We evaluated histology following a similar 19 neuromodulation FUS protocol as Lee et al. In macaques, there was no tissue damage following 20 500 bursts at tissue locations receiving intensities of 0.4, 1.6, 6.4, and 25.8 W/cm I . 21
Sonications of between 240 and 4800 bursts per location at intensity levels ranging from 0.6 22 and 13.8 W/cm I did not result in pre-mortem damage in sheep. Furthermore, we 23 evaluated histology from locations receiving between 128 and 8192 MR-ARFI bursts at a given 24 intensity level, ranging from 5.6 and 26.5 W/cm I , and found no pre-mortem damage from 25 either H&E-or TUNEL-stained tissue. One limitation of this study is that we did not detect tissue 26 damage with either MR-ARFI or neuromodulation FUS. 27
Skull bone absorbs and dephases ultrasound which introduces a risk of cortical heating, and has 28 been demonstrated to contribute to variations in FUS treatment across patients (Vyas et al. 29 2016). In our study, hydrophone measurements through ex vivo sheep skull caps resulted in a 30 range of estimated in situ intensities, even when similar acoustic power levels were applied ( Fig  31  4) . Particular attention has been paid to thermal rise during neuromodulation, and a recent 32
retrospective study has reported a simulated cortical temperature rise of 7 ∘ C caused by skull 33 heating during preclinical neuromodulation (Constans et al. 2018 sheep in the control group underwent MRI and anesthesia but no FUS. The eleven sheep that 33 underwent FUS were subdivided into acute (euthanized zero days after FUS study), delayed 34 (euthanized four to seven days after FUS study), repeated (underwent multiple FUS sessions, 35 and euthanized four days after the last FUS study), and high dose groups (underwent prolonged  36 MR-ARFI applications at one location on the last day of study). Days of survival following the 37 first (left-most) and subsequent days of study are reported in split columns where applicable, 38 for MRI without FUS (unshaded cells) and MRI with FUS sessions (shaded cells). (circles) were estimated to have in situ peak pressure between 1.7 and 3.6 MPa, which, due to 20 the short 16 ms sonication times, corresponded to between 5.6 and 26.5 W/cm I . 21
Neuromodulation sonications (triangles) were estimated to have peak in situ pressure between findings across all study groups, independent of whether any FUS was applied or which 37
hemisphere was sonicated (in the case of FUS application). Necrosis, macrophage infiltration, 38 red blood cell engulfment (erythrophagocytosis), and intracellular red blood cell breakdown 39 (hemosiderin-laden macrophages), which would be expected to accompany true pre-mortem 1 tissue damage, were not observed. 2 Figure 8 : Summary of parenchymal red blood cell extravasation foci in H&E-stained sheep brain 3 tissue slides. The number of foci per slide are shown for tissue taken from hemispheres without 4 FUS (blue dots) and hemispheres with FUS (yellow dots) for each study group where applicable. 5 Bars indicate mean and standard error. 6 
